Skip to content

BIORESTORATIVE THERAPIES, INC.: 10-Q filed 2015-08-14

What BIORESTORATIVE THERAPIES, INC. reported in its quarterly report filed 2015-08-14 (fiscal Q2 2015): 30 published measures, 78 facts as tagged in accession 0001144204-15-049960.

This filing

Form
10-Q (quarterly report)
Filed
2015-08-14
Fiscal period
fiscal Q2 2015
Accession
0001144204-15-049960 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All BIORESTORATIVE THERAPIES, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2015-06-302,070,578USD
At 2014-12-311,691,801USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2015-06-304,951,101USD
At 2014-12-318,580,194USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2015-06-30-2,880,523USD
At 2014-12-31-6,888,393USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2015-04-01 to 2015-06-30-1,420,298USD91
2015-01-01 to 2015-06-30-3,180,419USD181
2014-04-01 to 2014-06-30-1,333,139USD91
2014-01-01 to 2014-06-30-3,002,815USD181

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2015-01-01 to 2015-06-30151,914USD181
2014-01-01 to 2014-06-300USD181

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2015-04-01 to 2015-06-30148,764USD91
2015-01-01 to 2015-06-30333,666USD181
2014-04-01 to 2014-06-30175,941USD91
2014-01-01 to 2014-06-30176,316USD181

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2015-06-30-28,580,445USD
At 2014-12-31-25,400,026USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2015-06-30702,348USD
At 2014-12-31493,856USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2015-01-01 to 2015-06-30583,673USD181
2014-01-01 to 2014-06-30917,792USD181

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2015-04-01 to 2015-06-30-1,262,804USD91
2015-01-01 to 2015-06-30-2,888,770USD181
2014-04-01 to 2014-06-30-1,281,487USD91
2014-01-01 to 2014-06-30-2,709,905USD181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2015-06-30246,141USD
At 2014-12-31114,313USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2015-04-01 to 2015-06-3060,096USD91
2015-01-01 to 2015-06-30124,736USD181
2014-04-01 to 2014-06-3072,390USD91
2014-01-01 to 2014-06-30145,521USD181

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2015-06-304,919,562USD
At 2014-12-318,524,999USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2015-06-301,746,614USD
At 2014-12-311,111,879USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2015-06-3050,982USD
At 2014-12-310USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2015-04-01 to 2015-06-301,336,923USD91
2015-01-01 to 2015-06-303,071,359USD181
2014-04-01 to 2014-06-301,415,062USD91
2014-01-01 to 2014-06-302,843,795USD181

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2015-06-302,492USD
At 2014-12-311,945USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2015-04-01 to 2015-06-3074,119USD91
2015-01-01 to 2015-06-30182,589USD181
2014-04-01 to 2014-06-30133,575USD91
2014-01-01 to 2014-06-30133,890USD181

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2015-04-01 to 2015-06-30452,488USD91
2015-01-01 to 2015-06-30859,344USD181
2014-04-01 to 2014-06-30293,330USD91
2014-01-01 to 2014-06-30787,071USD181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2015-06-302,790,431shares
At 2014-12-311,697,664shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2015-06-3025,729,104USD
At 2014-12-3118,541,907USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2015-06-301,076,189USD
At 2014-12-311,037,732USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2015-06-301,887,484USD
At 2014-12-311,466,506USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2015-06-3034,055USD
At 2014-12-3120,570USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2015-04-01 to 2015-06-30696,353USD91
2015-01-01 to 2015-06-301,613,927USD181
2014-04-01 to 2014-06-30548,632USD91
2014-01-01 to 2014-06-301,184,632USD181

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2015-01-01 to 2015-06-3089,452USD181
2014-01-01 to 2014-06-3050,139USD181

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2015-04-01 to 2015-06-30-157,494USD91
2015-01-01 to 2015-06-30-291,649USD181
2014-04-01 to 2014-06-30-51,652USD91
2014-01-01 to 2014-06-30-292,910USD181

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2015-01-01 to 2015-06-3050,982USD181
2014-01-01 to 2014-06-300USD181

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2015-01-01 to 2015-06-30547USD181
2014-01-01 to 2014-06-30-175USD181

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2015-01-01 to 2015-06-30313,352USD181
2014-01-01 to 2014-06-30-369,047USD181

Inspect the source

Entity
BIORESTORATIVE THERAPIES, INC. / CIK 0001505497
Captured
2026-09-19T11:18:28.483Z
SEC response SHA-256
fd60c78bee3335eafd56c883fed2689ce9a2b29ba609bffc874788f5f89f9708

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001505497.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))